Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

6.41
+0.38006.30%
Volume:739.44K
Turnover:4.60M
Market Cap:288.44M
PE:-2.96
High:6.42
Open:5.99
Low:5.93
Close:6.03
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:0.73
T/O Rate:4.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:1.09
PE(LYR):-3.40

Loading ...

Sionna Therapeutics Q2 EPS $(0.66) Misses $(0.65) Estimate

Benzinga Earnings
·
Aug 06

Sionna Net Loss Widens 65.43% to $29.89 Million in Q2 FY26

Reuters
·
Aug 06

Sionna Therapeutics Inc Q2 Basic EPS USD -0.66

THOMSON REUTERS
·
Aug 06

Sionna Therapeutics Inc Q2 Operating Expenses USD 32.47 Million

THOMSON REUTERS
·
Aug 06

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live
·
Aug 05

Guggenheim Keeps Their Buy Rating on Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
Jul 27

Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Jul 20

Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns

Simply Wall St.
·
Jul 19

Sionna Therapeutics rises 9.2%

TIPRANKS
·
Jul 18

Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million

Reuters
·
Jul 10

Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of 10,250 Common Shares Worth $446,862.08

Reuters
·
Jul 08

Orbimed Advisors Disposes of 115,844 Sionna Therapeutics Shares Worth $5.27 Million

Reuters
·
Jul 03

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
Jun 25

Sionna Therapeutics: Buy Rating Reiterated on NBD1-Focused CF Strategy; $60 Price Target Maintained

TIPRANKS
·
Jun 22

Sionna Therapeutics shareholders elect Class II directors at annual meeting

Reuters
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
Jun 11

OrbiMed Advisors reports Sionna Therapeutics common stock sale valued at $4,493.49

Reuters
·
May 30

Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences

GlobeNewswire
·
May 27

Sionna Therapeutics Price Target Maintained With a $63.00/Share by Citizens

Dow Jones
·
May 26

Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 25